Skip to content

Taste Physiology in Obese Volunteers Before and After Bariatric Surgery

Taste Physiology in Obese Volunteers Before and After Bariatric Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02902198
Enrollment
16
Registered
2016-09-15
Start date
2014-12-31
Completion date
2027-12-31
Last updated
2025-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The objective is to investigate neuro-anatomical correlates of gastrointestinal taste stimulation by means of functional MRI before and after bariatric surgery. Intragastric administration of glucose, monosodium glutamate, chloroquine and placebo is followed by functional brain MRI in obese humans before and 3 months after surgery.

Interventions

DIETARY_SUPPLEMENTPlacebo

Tap water 200ml

DIETARY_SUPPLEMENTGlucose

25g Glucose in 200ml tap water

DIETARY_SUPPLEMENTMonosodium glutamate

1g monosodium glutamate in 200ml tap water

DIETARY_SUPPLEMENTQuinine

17mg quinine in 200ml tap water

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* morbidly obese patients (BMI min 35kg/m2) scheduled for bariatric surgery * right handed

Exclusion criteria

* cardiovascular disease * neurologic/psychiatric disorders

Design outcomes

Primary

MeasureTime frame
Effect of tastants on cerebral blood flow measured by functional brain MRIchanges from baseline to one hour after treatment

Secondary

MeasureTime frame
Effect of tastants plasma glucagon-like peptide (GLP-1) concentrationschanges from baseline to one hour after treatment
Effect of tastants plasma ghrelin concentrationschanges from baseline to one hour after treatment

Countries

Switzerland

Contacts

Primary ContactBettina Wölnerhanssen, Dr
bettina.woelnerhanssen@usb.ch

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026